{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T22:28:24Z","timestamp":1793572104786,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100006506","name":"Minist\u00e9rio da Sa\u00fade","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006506","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["444306\/2023-4"],"award-info":[{"award-number":["444306\/2023-4"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computational Biology and Chemistry"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.compbiolchem.2026.109264","type":"journal-article","created":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T15:45:45Z","timestamp":1785253545000},"page":"109264","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Deep learning-based prediction of drug\u2013target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach"],"prefix":"10.1016","volume":"125","author":[{"given":"Jackson G.","family":"de Souza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7536-2506","authenticated-orcid":false,"given":"Marcelo A.C.","family":"Fernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3798-5512","authenticated-orcid":false,"given":"Raquel","family":"de Melo Barbosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.compbiolchem.2026.109264_b1","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/07391102.2020.1819881","article-title":"Potential protease inhibitors and their combinations to block sars-cov-2","volume":"40","author":"Abhinand","year":"2020","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109264_b2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-89724-0","article-title":"Repurposing potential of posaconazole and grazoprevir as inhibitors of sars-cov-2 helicase","volume":"11","author":"Abidi","year":"2021","journal-title":"Sci. Rep."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109264_b3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s10557-020-07070-1","article-title":"Lopinavir-ritonavir in sars-cov-2 infection and drug-drug interactions with cardioactive medications","volume":"35","author":"Agarwal","year":"2020","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.compbiolchem.2026.109264_b4","series-title":"Drug-target interactions: Prediction methods and applications","author":"Anusuya","year":"2018"},{"issue":"8","key":"10.1016\/j.compbiolchem.2026.109264_b5","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/nrd1468","article-title":"Drug repositioning: identifying and developing new uses for existing drugs","volume":"3","author":"Ashburn","year":"2004","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109264_b6","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109133","article-title":"Hepatitis c virus drugs that inhibit sars-cov-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture","volume":"35","author":"Bafna","year":"2021","journal-title":"Cell Rep."},{"key":"10.1016\/j.compbiolchem.2026.109264_b7","series-title":"Computational target-based drug repurposing of elbasvir, an antiviral drug predicted to bind multiple sars-cov-2 proteins","author":"Balasubramaniam","year":"2020"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109264_b8","first-page":"1","article-title":"In silico proteome analysis of severe acute respiratory syndrome coronavirus 2 (sars-cov-2)","volume":"2","author":"Baruah","year":"2021","journal-title":"J. Nanotechnol. Nanomater."},{"key":"10.1016\/j.compbiolchem.2026.109264_b9","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1016\/j.csbj.2020.03.025","article-title":"Predicting commercially available antiviral drugs that may act on the novel coronavirus (sars-cov-2) through a drug-target interaction deep learning model","volume":"18","author":"Beck","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.compbiolchem.2026.109264_b10","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2020.173701","article-title":"In silico identification of strong binders of the sars-cov-2 receptor-binding domain","volume":"890","author":"Behloul","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.compbiolchem.2026.109264_b11","doi-asserted-by":"crossref","DOI":"10.1016\/j.meegid.2020.104451","article-title":"Identification of potential inhibitors against sars-cov-2 by targeting proteins responsible for envelope formation and virion assembly using docking based virtual screening, and pharmacokinetics approaches","volume":"84","author":"Bhowmik","year":"2020","journal-title":"Infect. Genet. Evol."},{"issue":"19","key":"10.1016\/j.compbiolchem.2026.109264_b12","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa2001282","article-title":"A trial of lopinavir-ritonavir in adults hospitalized with severe covid-19","volume":"382","author":"Cao","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109264_b13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3390\/ph15010021","article-title":"Atazanavir is a competitive inhibitor of sars-cov-2 mpro, impairing variants replication in vitro and in vivo","volume":"15","author":"Chaves","year":"2021","journal-title":"Pharmaceuticals"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109264_b14","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3390\/v14071458","article-title":"Commercially available flavonols are better sars-cov-2 inhibitors than isoflavone and flavones","volume":"14","author":"Chaves","year":"2022","journal-title":"Viruses"},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109264_b15","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1208\/s12248-017-0092-6","article-title":"Large-scale prediction of drug-target interaction: a data-centric review","volume":"19","author":"Cheng","year":"2017","journal-title":"AAPS J."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109264_b16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijantimicag.2008.10.010","article-title":"Anti-hiv drugs: 25 compounds approved within 25 years after the discovery of hiv","volume":"33","author":"Clercq","year":"2009","journal-title":"Int. J. Antimicro. Ag."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109264_b17","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2165\/11209110-000000000-00000","article-title":"Etravirine: A review of its use in the management of treatment-experienced patients with hiv-1 infection","volume":"72","author":"Croxtall","year":"2012","journal-title":"Drugs"},{"issue":"11","key":"10.1016\/j.compbiolchem.2026.109264_b18","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1038\/nbt.1990","article-title":"Comprehensive analysis of kinase inhibitor selectivity","volume":"29","author":"Davis","year":"2011","journal-title":"Nature Biotechnol."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109264_b19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3390\/pharmaceutics14030625","article-title":"A novel deep neural network technique for drug\u2013target interaction","volume":"14","author":"de Souza","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.compbiolchem.2026.109264_b20","first-page":"1","article-title":"Exploring binding mechanisms of omicron spike protein with dolutegravir and etravirine by molecular dynamics simulation, principal component analysis, and free binding energy calculations","author":"Elseginy","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"10","key":"10.1016\/j.compbiolchem.2026.109264_b21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.00825-20","article-title":"Atazanavir, alone or in combination with ritonavir, inhibits sars-cov-2 replication and proinflammatory cytokine production","volume":"64","author":"Fintelman-Rodrigues","year":"2020","journal-title":"Antimicrob. Agents. Chemother."},{"key":"10.1016\/j.compbiolchem.2026.109264_b22","series-title":"Atazanavir inhibits sars-cov-2 replication and pro-inflammatory cytokine production","author":"Fintelman-Rodrigues","year":"2020"},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109264_b23","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1517\/13543784.2014.902049","article-title":"Mk-5172: a second-generation protease inhibitor for the treatment of hepatitis c virus infection","volume":"23","author":"Gentile","year":"2014","journal-title":"Expert. Opin. Investig. Drugs"},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109264_b24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1093\/biomet\/92.4.965","article-title":"Concordance probability and discriminatory power in proportional hazards regression","volume":"92","author":"G\u00f6nen","year":"2005","journal-title":"Biometrika"},{"issue":"7816","key":"10.1016\/j.compbiolchem.2026.109264_b25","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1038\/s41586-020-2286-9","article-title":"A sars-cov-2 protein interaction map reveals targets for drug repurposing","volume":"583","author":"Gordon","year":"2020","journal-title":"Nature"},{"issue":"16","key":"10.1016\/j.compbiolchem.2026.109264_b26","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.2165\/00003495-200565160-00010","article-title":"Atazanavir: A review of its use in the management of hiv infection","volume":"65","author":"Harrison","year":"2005","journal-title":"Drugs"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109264_b27","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13321-017-0209-z","article-title":"Simboost: a read-across approach for predicting drug-target binding affinities using gradient boosting machines","volume":"9","author":"He","year":"2017","journal-title":"J. Cheminformatics"},{"key":"10.1016\/j.compbiolchem.2026.109264_b28","series-title":"Therapeutics data commons: Machine learning datasets and tasks for therapeutics","author":"Huang","year":"2021"},{"issue":"12","key":"10.1016\/j.compbiolchem.2026.109264_b29","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1016\/j.jiph.2020.10.015","article-title":"Raltegravir, indinavir, tipranavir, dolutegravir, and etravirine against main protease and rna-dependent rna polymerase of sars-cov-2: A molecular docking and drug repurposing approach","volume":"13","author":"Indu","year":"2020","journal-title":"J. Infect. Public Health"},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109264_b30","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-023-01104-5","article-title":"Structural and non-structural proteins in sars-cov-2: potential aspects to covid-19 treatment or prevention of progression of related diseases","volume":"21","author":"Kakavandi","year":"2023","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.compbiolchem.2026.109264_b31","series-title":"Adam: A method for stochastic optimization","author":"Kingma","year":"2017"},{"issue":"7366","key":"10.1016\/j.compbiolchem.2026.109264_b32","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/477526a","article-title":"Translational research: 4 ways to fix the clinical trial","volume":"477","author":"Ledford","year":"2011","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.compbiolchem.2026.109264_b33","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.3390\/ijms23074050","article-title":"Identification of entry inhibitors against delta and omicron variants of sars-cov-2","volume":"23","author":"Lee","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"Database","key":"10.1016\/j.compbiolchem.2026.109264_b34","doi-asserted-by":"crossref","first-page":"D198","DOI":"10.1093\/nar\/gkl999","article-title":"Bindingdb: a web-accessible database of experimentally determined protein-ligand binding affinities","volume":"35","author":"Liu","year":"2007","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.compbiolchem.2026.109264_b35","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1021\/acscentsci.0c01186","article-title":"Simeprevir potently suppresses sars-cov-2 replication and synergizes with remdesivir","volume":"7","author":"Lo","year":"2021","journal-title":"ACS Central Sci."},{"key":"10.1016\/j.compbiolchem.2026.109264_b36","doi-asserted-by":"crossref","DOI":"10.1016\/j.antiviral.2022.105419","article-title":"Repurposing of hiv\/hcv protease inhibitors against sars-cov-2 3clpro","volume":"207","author":"Ma","year":"2022","journal-title":"Antiviral Res."},{"issue":"14","key":"10.1016\/j.compbiolchem.2026.109264_b37","doi-asserted-by":"crossref","first-page":"6569","DOI":"10.1080\/07391102.2021.1886991","article-title":"In silico prediction of sars-cov-2 main protease and polymerase inhibitors: 3d-pharmacophore modelling","volume":"40","author":"Mosayebnia","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.compbiolchem.2026.109264_b38","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijantimicag.2021.106499","article-title":"Effects of simeprevir on the replication of sars-cov-2 in vitro and in transgenic hace2 mice","volume":"59","author":"Muturi","year":"2022","journal-title":"Int. J. Antimicro. Ag."},{"issue":"19","key":"10.1016\/j.compbiolchem.2026.109264_b39","doi-asserted-by":"crossref","first-page":"8989","DOI":"10.1080\/07391102.2021.1921033","article-title":"Antivirals virtual screening to sars-cov-2 non-structural proteins","volume":"40","author":"Nunes","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"30423097","key":"10.1016\/j.compbiolchem.2026.109264_b40","first-page":"i821","article-title":"Deepdta: deep drug-target binding affinity prediction","volume":"34","author":"\u00d6zt\u00fcrk","year":"2018","journal-title":"Bioinform. (Oxford, England)"},{"key":"10.1016\/j.compbiolchem.2026.109264_b41","series-title":"Widedta: prediction of drug-target binding affinity","author":"\u00d6zt\u00fcrk","year":"2019"},{"issue":"17","key":"10.1016\/j.compbiolchem.2026.109264_b42","doi-asserted-by":"crossref","first-page":"4853","DOI":"10.1016\/j.bmcl.2008.07.088","article-title":"Structure\u2013activity relationship study on a novel series of cyclopentane-containing macrocyclic inhibitors of the hepatitis c virus ns3\/4a protease leading to the discovery of tmc435350","volume":"18","author":"Raboisson","year":"2008","journal-title":"Bioorganic Med. Chem. Lett."},{"key":"10.1016\/j.compbiolchem.2026.109264_b43","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbi.2019.103159","article-title":"A comprehensive review of feature based methods for drug target interaction prediction","volume":"93","author":"Sachdev","year":"2019","journal-title":"J. Biomed. Inform."},{"issue":"D1","key":"10.1016\/j.compbiolchem.2026.109264_b44","doi-asserted-by":"crossref","first-page":"D20","DOI":"10.1093\/nar\/gkab1112","article-title":"Database resources of the national center for biotechnology information","volume":"50","author":"Sayers","year":"2021","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.compbiolchem.2026.109264_b45","series-title":"Proceedings of the Machine Learning for Healthcare Conference","first-page":"230","article-title":"Self-attention based molecule representation for predicting drug-target interaction","volume":"vol. 106","author":"Shin","year":"2019"},{"issue":"56","key":"10.1016\/j.compbiolchem.2026.109264_b46","first-page":"1929","article-title":"Dropout: A simple way to prevent neural networks from overfitting","volume":"15","author":"Srivastava","year":"2014","journal-title":"J. Mach. Learn. Res."},{"issue":"4","key":"10.1016\/j.compbiolchem.2026.109264_b47","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0849-9","article-title":"Lopinavir\u2013ritonavir in severe covid-19","volume":"26","author":"Stower","year":"2020","journal-title":"Nature Med."},{"issue":"3","key":"10.1016\/j.compbiolchem.2026.109264_b48","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1021\/ci400709d","article-title":"Making sense of large-scale kinase inhibitor bioactivity data sets: A comparative and integrative analysis","volume":"54","author":"Tang","year":"2014","journal-title":"J. Chem. Inf. Model."},{"issue":"9","key":"10.1016\/j.compbiolchem.2026.109264_b49","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/QAD.0000000000003577","article-title":"No association between use of tenofovir disoproxil fumarate, etravirine, or integrase-strand transfer inhibitors and acquisition or severe outcomes of sars-cov-2 infection in people with hiv in the netherlands","volume":"37","author":"Verburgh","year":"2023","journal-title":"AIDS"},{"key":"10.1016\/j.compbiolchem.2026.109264_b50","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.587269","article-title":"Sars-cov-2: Structure, biology, and structure-based therapeutics development","volume":"10","author":"Wang","year":"2020","journal-title":"Front. Cell. Infect. Microbiol."},{"issue":"6","key":"10.1016\/j.compbiolchem.2026.109264_b51","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1002\/jmv.25729","article-title":"A systematic review of lopinavir therapy for sars coronavirus and mers coronavirus\u2014a possible reference for coronavirus disease-19 treatment option","volume":"92","author":"Yao","year":"2020","journal-title":"J. Med. Virol."}],"container-title":["Computational Biology and Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126003919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1476927126003919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:44:38Z","timestamp":1793148278000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1476927126003919"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":51,"alternative-id":["S1476927126003919"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109264","relation":{},"ISSN":["1476-9271"],"issn-type":[{"value":"1476-9271","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Deep learning-based prediction of drug\u2013target interactions between antiviral drugs and SARS-CoV-2 proteins using an image-based representation approach","name":"articletitle","label":"Article Title"},{"value":"Computational Biology and Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiolchem.2026.109264","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"109264"}}